Low Dose Naltrexone Therapy for Cancer Treatment
What is Low Dose Naltrexone (LDN)?
Low Dose Naltrexone (LDN) is used in the treatment of cancer as a long-term stabilization and/or gradual reduction of tumor mass volume.
How It Works
- Induces an increase of metenkephalin (an endorphin produced in large amounts in the adrenal medulla) and beta-endorphin in the bloodstream.
- Induces increase in the number and density of opiate receptors on the tumor cell membranes by making them more responsive to the growth-inhibiting effects of the already-present levels of endorphins, which induce apoptosis (cell death) in cancer cells.
- Increases the natural killer (NK) cell numbers and NK cell activity.
Cancers that Respond to LDN
Bladder Cancer
Breast Cancer
Carcinoid
Colon & Rectal Cancer
Glioblastoma
Liver Cancer
Lung Cancer (Non-Small Cell)
Lymphocytic Leukemia (Chronic)
Lymphoma (Hodgkin’s and Non-Hodgkin’s)
Malignant Melanoma
Multiple Myeloma
Neuroblastoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer (Untreated)
Renal Cell Carcinoma
Throat Cancer
Uterine Cancer
Call (949) 581-HOPE (4673), email us at info@cancercenterforhealing.com , or chat with us live to schedule your appointment. We are here to answer any questions and to help you schedule a personal consultation with an Integrative Cancer Specialist.